This trial is testing an investigational medication in people who have early Alzheimer’s disease. Researchers want to learn about the safety of the investigational medication and how well it may work to slow the progression of Alzheimer’s disease.
Study of MK-2214 in Participants with Early Alzheimer’s Disease
Dementia and cognitive impairmentOpen for recruitment
